首页> 外文OA文献 >PCN20 COST-EFFECTIVENESS OF CETUXIMAB (ERBITUX®) IN COMBINATION WITH RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN THE TREATMENT OF LOCALLY ADVANCED HEAD AND NECK CANCER IN THE UNITED KINGDOM

【2h】

PCN20 COST-EFFECTIVENESS OF CETUXIMAB (ERBITUX®) IN COMBINATION WITH RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN THE TREATMENT OF LOCALLY ADVANCED HEAD AND NECK CANCER IN THE UNITED KINGDOM

机译：头孢昔单抗（ERBITUX®）与放射治疗与放射治疗相结合单独治疗PCN20在英国局部先进的头部和颈部癌症中的治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Brown B; Tilden D; Griebsch I; Ralston SJ;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (Head and neck cancer: ImmunoChemo and Radiotherapy with Erbitux) – a multicenter phase IV trial [J] . G Habl, K Potthoff, MF Haefner, BMC Cancer . 2013,第1期

机译：接受放射免疫治疗的局部晚期头颈癌患者的放射和西妥昔单抗诱导的皮肤反应的区别：HICARE方案（头颈癌：ImmunoChemo和放射治疗）–多中心IV期试验
2. An economic evaluation of cetuximab combined with radiotherapy for patients with locally advanced head and neck cancer in Belgium, France, Italy, Switzerland, and the United Kingdom. [J] . Brown B, Diamantopoulos A, Bernier J, Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2008,第5期

机译：在比利时，法国，意大利，瑞士和英国对西妥昔单抗联合放疗进行局部晚期头颈癌患者的经济评估。
3. Cetuximab and radiotherapy versus cisplatin and radiotherapy for locally-advanced head and neck cancer: a randomized phase II trial [J] . Vozy A., Cuenca X. Oncologie. . 2016,第6期

机译：西妥昔单抗和放疗与顺铂和放疗治疗局部晚期头颈癌：一项随机II期试验
4. A simple method for EPID-based in vivo dosimetry for radiotherapy treatments of head-and-neck cancers [C] . T. Kairn, S.B. Crowe, J.V. Trapp World Congress on Medical Physics and Biomedical Engineering . 2013

机译：基于EPID的体内剂量学的简单方法用于头颈癌的放射治疗
5. Image-guided adaptive radiotherapy for prostate and head-and-neck cancers. [D] . O'Daniel, Jennifer C. 2006

机译：针对前列腺癌和头颈癌的影像引导自适应放射治疗。
6. Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (Head and neck cancer: ImmunoChemo and Radiotherapy with Erbitux) – a multicenter phase IV trial [O] . G Habl, K Potthoff, MF Haefner, 2013

机译：接受放射免疫治疗的局部晚期头颈癌患者的辐射和西妥昔单抗诱导的皮肤反应的区别：HICARE方案（头颈癌：ImmunoChemo和放射治疗）–多中心IV期试验
7. PCN43 COST-EFFECTIVENESS OF CETUXIMAB (ERBITUX®) IN COMBINATION WITH RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN THE TREATMENT OF LOCALLY ADVANCED HEAD AND NECK CANCER IN FRANCE [O] . Brown B, Robinson P, Launois R, 2006

机译：PCN43头孢昔布（ERBITUX®）与放疗对比放疗联合治疗法国局部高级头颈癌的成本效益
8. Efforts for Improvement in Radiotherapy of Cancer Using Metronidazole with Special Regard to Head and Neck. Part of a Coordinated Programme on Improvement of Cancer Therapy by the Combination Treatment of Conventional Radiation an [R] . Patricio, M. B. 1984

机译：利用甲硝唑特别针对头颈部改善癌症放射治疗的努力。通过常规辐射联合治疗改善癌症治疗的协调计划的一部分

PCN20 COST-EFFECTIVENESS OF CETUXIMAB (ERBITUX®) IN COMBINATION WITH RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN THE TREATMENT OF LOCALLY ADVANCED HEAD AND NECK CANCER IN THE UNITED KINGDOM

著录项

引文网络

相似文献

相关主题

期刊订阅